Marco Orleni

6PUBLICATIONS
19CO-AUTHORS
Characterisation of biological macromoleculesAnalytical spectrometryPharmaceutical delivery technologiesImmunogenetics (incl. genetic immunology)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Oct 16, 2024
Quantification of Letrozole, Palbociclib, Ribociclib, Abemaciclib, and Metabolites in Volumetric Dried Blood Spots: Development and Validation of an LC-MS/MS Method for Therapeutic Drug Monitoring.

Eleonora Cecchin, Marco Orleni, Sara Gagno

|May 24, 2024
Quantitation of tazemetostat in human plasma using liquid chromatography-tandem mass spectrometry.

Marco Orleni, Robert A Parise, Julianne L Holleran

|Jun 15, 2023
The use of therapeutic drug monitoring to highlight an over-looked drug-drug interaction leading to imatinib treatment failure.

Sara Gagno, Angela Buonadonna, Chiara Dalle Fratte

|May 27, 2023
LC-MS/MS Method for the Quantification of PARP Inhibitors Olaparib, Rucaparib and Niraparib in Human Plasma and Dried Blood Spot: Development, Validation and Clinical Validation for Therapeutic Drug Monitoring.

Giovanni Canil, Marco Orleni, Bianca Posocco

|Feb 25, 2023
Impact of <i>ABCG2</i> and <i>ABCB1</i> Polymorphisms on Imatinib Plasmatic Exposure: An Original Work and Meta-Analysis.

Chiara Dalle Fratte, Jerry Polesel, Sara Gagno

|Oct 26, 2021
A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring.

Martina Zanchetta, Valentina Iacuzzi, Bianca Posocco

Pageof 1

Frequent Collaborators

5 joint publications

Giuseppe Toffoli

4 joint publications

Rossana Roncato

3 joint publications

Fabio Puglisi

3 joint publications

Erika Cecchin